Elexacaftor-Tezacaftor-Ivacaftor for Individuals with Residual CFTR Activity: An Open-Label, Nonrandomized Clinical Trial. - Linnemann RW; Solomon GM; Westbrook AL; Rich R; Streby A; Hunter E; Rab A; Bai S; Mcnicholas CM; Hong JS; Manfredi C; Hunt WR; et al. (Annals of the American Thoracic Society, 2026)